Five entities – four companies and one executive – are now being probed by the Competition Commission of India after complaints of anticompetitive stockiest-ship appointments. Pharmaceutical companies Cipla, Macleods Pharmaceutical and FDC Ltd are all under investigation, as well as the trade body Himachal Pradesh Society of Chemist and Druggist Alliance, as well as its president. According to reports, the CCI is looking into allegations that the trade body illegally controlled the appointment of stockist-ship of the pharmaceutical companies that are part of the Society. The CCI has recognized the complaints that competitors could not be granted stockish-ship due to the collusive agreements.
Featured News
US Appeals Court Tosses FTC Order Over Intuit’s “Free” TurboTax Ads
Mar 22, 2026 by
CPI
Jury Finds Musk Liable for Misleading Twitter Shareholders During Takeover Fight
Mar 22, 2026 by
CPI
FTC Launches Healthcare Task Force to Sharpen Enforcement
Mar 22, 2026 by
CPI
White House Pushes Congress for National AI Law to Override State Rules
Mar 22, 2026 by
CPI
Anthropic Copyright Settlement Lawyers Cut Fee Request to $187.5 Million
Mar 22, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Data-Driven Competition
Mar 19, 2026 by
CPI
Data-Driven Competition: Implications For Enforcement and Merger Control
Mar 19, 2026 by
Alexandre de Corniere & Greg Taylor
From Tipping to Trustees: Why Data-Driven Markets Require Institutional Design, Not Optimization
Mar 19, 2026 by
Jens Prüfer & Paul de Bijl
Data Barriers to Entry: What We’ve Learned About Spotting Them and What We Still Don’t Know About Solutions
Mar 19, 2026 by
Bruno Carballa-Smichowski
When the Perfect Is the Enemy of the Good: Price Discrimination, Affordability, Precarity and Market Dynamism
Mar 19, 2026 by
Dan Ciuriak